We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Clinical Omics – News and Features

COVID-19 Multiomics Research: Strategies, Insights and Tools  content piece image
Article

COVID-19 Multiomics Research: Strategies, Insights and Tools

In this article, we explore multiomic approaches to COVID-19 research and explore some of the computational and statistical tools being developed to support multiomic analyses.
Whole Genome Sequencing Enables More Precise Diagnoses for Patients With Rare Diseases content piece image
News

Whole Genome Sequencing Enables More Precise Diagnoses for Patients With Rare Diseases

More than 1,200 people with rare diseases have received a diagnosis thanks to the integration of large-scale genomics into the Stockholm region's healthcare system.
News

A Rapid Genomics Strategy To Trace Coronavirus

Researchers have created a rapid genome sequencing strategy for the coronavirus.
Mapping the Human Proteome: A Journey content piece image
Article

Mapping the Human Proteome: A Journey

In 2020, we celebrate 90% of the human proteome being mapped by the Human Proteome Project (HPP). In this article, we reflect on the history of this endeavor and the future of the proteomics field, speaking with individuals close to the project.
News

Collaborations Aim To Meet Unmet Clinical Needs in Biomarker Discovery and Characterization

Thermo Fisher Scientific announced agreements with AstraZeneca and the University of Nebraska Medical Center that will showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis.
Industry Insight

Breaking Down Barriers in Proteomic-Based Drug Discovery

SomaLogic recently announced an agreement with the biopharmaceutical company Amgen that aims to advance Amgen's drug discovery and development programs through comprehensive proteomic profiling. We spoke with Roy Smythe to discover what barriers have been holding proteome analysis back, and how the collaboration with Amgen aims to change the landscape of drug discovery.
Towards a Deeper Understanding of the Proteomic Landscape content piece image
Industry Insight

Towards a Deeper Understanding of the Proteomic Landscape

At a recent London Proteomics Discussion Group Meeting, Professor Roman Fischer kicked off the event by addressing the apparent "failure" of proteomics to deliver new clinical biomarkers thus far. Technology Networks sat down with Fischer to discuss spatial proteomics, and to expand on some of the key aspects of his research.
A Fusion of Proteomic Practices: The Indisputable Complementarity of "Bottom-Up" and "Top-Down" Approaches content piece image
Article

A Fusion of Proteomic Practices: The Indisputable Complementarity of "Bottom-Up" and "Top-Down" Approaches

In this article, we explore the two principal tracks that are used to identify and characterize proteins by mass spectrometry – "bottom-up" and "top-down" proteomics.
News

Differences Identified Between Blood Samples of Patients With Mild Versus Severe COVID-19 Clinical Signs

Researchers have identified 27 proteins that are present at different levels in the blood of COVID-19 patients, depending on the severity of their symptoms.
Article

A Global Mass Spectrometry Coalition To Combat COVID-19

A global coalition involving over 500 scientists, known as the COVID-19 MS Coalition, was announced earlier this week. The coalition aims to share mass spectrometry data on COVID-19 for the purpose of novel biomarker discovery and understanding the infection more deeply at a molecular level. Technology Networks spoke with Perdita Barran to find out more.
Advertisement